Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Krishnamurthy Nirup

2. Date of Event Requiring Statement (MM/DD/YYYY) 9/9/2020

3. Issuer Name and Ticker or Trading Symbol

Medicine Man Technologies, Inc. [SHWZ]

(Last) (First) (Middle)

4880 HAVANA STREET, SUITE 201

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Operating Officer /

(Street)

DENVER, CO 80239

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	⁽²⁾	Common Stock	300000	$1.78	D
Options	⁽³⁾	⁽²⁾	Common Stock	300000	$3.83	D

Explanation of Responses:
(1)	On March 5, 2020, the reporting purchase received 300,000 options to purchase the registrant's common stock, of which 150,000 options vest and become exercisable on the anniversary of the date of grant beginning in the year 2022, such that the options are fully exercisable on March 5, 2023.
(2)	The options are exercisable three years from the date of vest.
(3)	On June 5, 2019, the reporting purchase received 300,000 options to purchase the registrant's common stock, of which 150,000 options vest and become exercisable on the anniversary of the date of grant, beginning in the year 2020, such that the options are fully exercisable on June 5, 2021.

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Krishnamurthy Nirup 4880 HAVANA STREET, SUITE 201 DENVER, CO 80239			Chief Operating Officer